Each month, we compile and present a comprehensive up-to-date list of recently started clinical trials to keep you informed of the latest advancements and research in the medical field. To be the first to know about new clinical trials Register Now for free

The below are the clinical trials posted for the first time in September 2024.

Phase 4:

  1. Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm
  2. An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer
  3. Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
  4. Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy
  5. Secondary Prevention of VTE in Patients with Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
  6. Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
  7. "cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular Carcinoma
  8. Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC
  9. Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

Phase 3:

  1. Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer
  2. Total RadIoTherapy of Oligometastatic caNcerS
  3. Comparison Partial Versus Total Omentectomy in Minimal Invasive Distal Gastrectomy for cT3/4a Gastric Cancer (KLASS-10)
  4. Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without Chemoimmunotherapy
  5. Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer
  6. Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
  7. Extending Outcomes for Pancreas Cancer Patients with Nominal Oligometastatic Disease (EXPAND): a Randomized Phase III Trial
  8. A Randomized Trial Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Over-Expressed Refractory Metastatic Colorectal Cancer
  9. PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer
  10. AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer
  11. Docetaxel and Hormone Treatment Compared to Hormone Treatment Alone in People With Metastatic Castration Sensitive Prostate Cancer and Less Than Optimal PSA Response
  12. Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumav Plus Platinum-based Chemotherapy As Neoadjuvant Therapy in Patients with Resectable Stage β…΅-β…Ά Non-small Cell Lung Cancer: a Phase β…Ά, Randomized, Multicenter, Prospective Study
  13. Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause with Previous Breast Cancer
  14. JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer
  15. A Phase III Study to Evaluate the Efficacy and Safety of YL201 in Relapsed Small Cell Lung Cancer
  16. Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer
  17. First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study
  18. A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer
  19. A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC
  20. Evaluating the Efficacy and Safety of Adebrelimab in Combination with Chemotherapy and LDRT As 1L Treatment for ES-SCLC
  21. Integrated Pharmacokinetics (PK)/efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to OpdivoΒ® in Combination with YervoyΒ®
  22. Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
  23. 9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer
  24. PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
  25. Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
  26. A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
  27. Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
  28. Twice-per-weekSelinexor, 2 Days Melphalan
  29. A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-refractory Multiple Myeloma (QUINTESSENTIAL-2)
  30. Olanzapine 2.5 Vs 5 Mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan
  31. PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
  32. Seronegative Myasthenia Gravis - Efgartigimod IV

Phase 2-3:

  1. Vitamin C Plus Herbal Medicine to Chemotherapy Related Anemia in Pancreatic Cancer
  2. Vitamin C Plus Herbal Medicine to Quality of Life in Patients with Terminal Stage Pancreatic Cancer
  3. A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-NaΓ―ve Adult Patients With Metastatic Uveal Melanoma
  4. Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
  5. Effectivity of Protein Purified Derivative Treatment for Anogenital Warts in HIV Patient
  6. Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia

Phase 2:

  1. Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
  2. Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors
  3. Study in Children and Adolescents of 177Lu-DOTATATE (LutatheraΒ®) Combined with the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
  4. Organoid-driven Chemotherapy Choice in Metastatic Pancreatic Cancer Patients.
  5. A Phase 2 Study Evaluating Olutasidenib in Combination with Hypomethylating Agents in Patients with IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm
  6. SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx
  7. Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial)
  8. HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
  9. A Clinical Study Based on FAPI-PET/CT Technology to Predict Pathological Complete Response After Neoadjuvant Chemoradiotherapy for MSS Rectal Cancer
  10. Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer
  11. Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC
  12. Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy
  13. Castrate Resistant Prostate Cancer Enhertu Therapy
  14. Working Out M0 Bipolar Androgen Therapy
  15. Phase II Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
  16. Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)
  17. GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC
  18. Hypofractionated WPPT with HDR Boost
  19. Adebrelimab Combined with Dalpiciclib and Standard Endocrine Therapy for HR + / HER2- Breast Cancer
  20. Effect of Capivasertib on ctDNA in ER Positive Breast Cancer
  21. Adebrelimab and Chidamide for Pancreatic Cancer
  22. Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
  23. TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer
  24. Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients with Locally Advanced or Metastatic Gallbladder Cancer
  25. Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Nagative Breast Cancer
  26. A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC
  27. A Single-arm, Prospective Phase β…΅ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC
  28. Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer
  29. Node-Sparing Short-Course Radiation with CAPOX and Sintilimab for MSS Locally Advanced Colon Cancer: a Randomized, Prospective, Multicenter Study
  30. PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
  31. Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
  32. Evaluation of the Safety and Efficacy of Treatment W/High Dose Melphalan Given Directly Into the Liver Followed by Treatment W/approved Cancer Treatment or Approved Cancer Treatment Alone in Patients W/ Metastatic Colorectal Cancer W/liver Dominant Disease
  33. A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLM
  34. A Study of Sotorasib in People With Non-Small Cell Lung Cancer
  35. HER2 Molecular Imaging with 89Zr-trastuzumab PET/CT As a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients with Advanced HER2-positive Breast Cancer
  36. A Study of Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer Tumors
  37. A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)
  38. Adebrelimab Combined With Capecitabine for Adjuvant Therapy in Cholangiocarcinoma With High-risk Recurrence Post-surgery
  39. Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRT
  40. A Phase 2 Study of AMG 193 in Participants With MTAP-deleted Advanced NSCLC
  41. Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer
  42. A Study of Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung Cancer
  43. Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction
  44. First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy
  45. JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases
  46. Evaluating the Benefits of Personalized Traditional Chinese Medicine in Postoperative Treatment for Locally Advanced Colorectal Cancer
  47. Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
  48. Vitamin D Supplementation in Breast Cancer Patients
  49. Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer Patients
  50. Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
  51. Medical Cannabis in Patients With Advanced Pancreatic Cancer
  52. Neoajuvant Tislelizumab Combined with Chemotherapy for Initially Unresectable Stage IIIA/N2 Non-small Cell Lung Cancer
  53. A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
  54. Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial
  55. Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis
  56. Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer
  57. Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases
  58. The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis
  59. Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer
  60. JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
  61. A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
  62. Irinotecan Hydrochloride Liposome Injection (β…΅) Combined with Fluorouracil, Folinic Acid, Vermofenib and Cetuximab in First-line Treatment of BRAFV600E Mutated Advanced Colorectal Cancer
  63. The Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced, Recurrent, or Metastatic CLDN18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
  64. Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC
  65. A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC
  66. Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC
  67. BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
  68. The Purpose of This Study is to Evaluate the Safety and Efficacy of D-MNA in Adult Patients With Nodular Basal Cell Carcinoma
  69. GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma
  70. Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)
  71. mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria
  72. Hyperpolarized 13C-MRI in Patients with Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab
  73. Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment
  74. The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities
  75. Phase II Study of PD-1 Antibody Combined with Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma
  76. 68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.
  77. VA as Maintenance Therapy Post Allo-HSCT in MDS and AML
  78. Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
  79. TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.
  80. TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
  81. Study of HMPL-760 Puls R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
  82. Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
  83. Orelabrutinib Followed by Response-adapted Ultra-low Dose 4Gy Radiation as First-line Treatment of MALT Lymphoma
  84. Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma
  85. Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.
  86. Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia
  87. BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma.
  88. Molecular Subtype-Guided R-CHOP-MTXΒ±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement
  89. Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy
  90. A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
  91. A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  92. RSV Vaccination in Immunocompromised Patients.
  93. A Multicenter, Randomized, Double-blind, Placebo-parallel-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of HRS9531 Injection in Obese Subjects With Polycystic Ovary Syndrome

Phase 1-2:

  1. Using CICS-1 and SPM-011 and οΌ»18FοΌ½FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA
  2. Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients With Advanced Malignant Solid Tumours.
  3. A Modular Phase 1/2 Study with CT7439 in Participants with Solid Malignancies
  4. A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors
  5. First-in-human Study of CRB-601-01 to Treat Patients with Advanced Solid Tumor.
  6. A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
  7. A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors
  8. A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation
  9. Personalized Neoantigen Cancer Vaccine for Patients with Solid Tumors
  10. Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011)
  11. Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials
  12. A Study to Determine the Effect of CT3001 in Patients with Advanced Solid Tumors
  13. A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
  14. Safety and Efficacy of Cryoablation With Karelizumab and Apatinib for Multiple Lung Cancers
  15. A Study of Niraparib in Combination with Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL)
  16. Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
  17. Trial of 225Ac-DOTATATE (RYZ101) Alone and with Pembrolizumab in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs
  18. The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer
  19. Clinical Study to Evaluate Debio0123 + Sacituzumab Govitecan Combination in TNBC or HR+/HER2- Advanced Breast Cancer
  20. A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC
  21. Surgery for Ovarian Cancer After PARPi Therapy in Precision
  22. A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  23. Green Tea and Quercetin in Combination with Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
  24. PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
  25. LSTA1 Phase 1b/2a Continuous Infusion Trial in mPDAC
  26. Auto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLC
  27. Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
  28. Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy
  29. SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt
  30. BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma
  31. A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/recurrent Hepatocellular Carcinoma (HCC)
  32. A Study of Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma
  33. Study of ODX (OsteoDex) in Multiple Myeloma
  34. Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell in Patients With Relapsed/Refractory Acute Leukemia
  35. CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma
  36. R-CMOP in Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma
  37. Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients (MZL)
  38. Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?!

Phase 1:

  1. Impact of Daily Oral Cannabis Doses in Patients with Cancer
  2. A Phase 1 Study of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors
  3. UBX-303061 in Subjects with Relapsed/Refractory B-Cell Malignancies
  4. A Study of BG-C477 in Participants With Advanced Solid Tumors
  5. Oral Paclitaxel for Patients with Advanced Solid Tumors
  6. A Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of HRS-4508 Monotherapy in Patients With Advanced or Metastatic Solid Tumors
  7. A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor
  8. ORB-021 In Patients With Advanced Solid Tumors
  9. Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With Chemotherapy
  10. HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
  11. A Study of Exercise Therapy in People With Solid Tumor Cancer
  12. AMT-754 in Patients With Selected Advanced Solid Tumours
  13. An Investigational Study of BGB-58067 in Participants With Advanced Solid Tumors
  14. Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors
  15. Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers
  16. A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
  17. To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid Tumors
  18. CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms
  19. A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
  20. A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors
  21. A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
  22. Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors
  23. A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors
  24. Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
  25. Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
  26. U87 CAR-T in Patients With Advanced Head and Neck Tumors
  27. Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers
  28. Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors
  29. A Study with NKT3964 for Adults with Advanced/Metastatic Solid Tumors
  30. A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
  31. NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique
  32. A Phase 1 Dose Escalation Study of ZG006 in Patients with Small Cell Lung Cancer
  33. Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
  34. A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants with Advanced or Metastatic Solid Tumors with KRAS Mutations or Amplification
  35. Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
  36. A Phase Ib Study of Rezatapopt in Combination with Azacitidine or Azacitidine and Venetoclax in Patients with TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
  37. A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients with Advanced Metastatic Castration Resistant Prostate Cancer
  38. Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With Plixorafenib
  39. Comparison Between Epidural Analgesia and Intrathecal Opioid Analgesia for Pain Management in Open Nephrectomy
  40. Study of IBI3009 in Subjects With Unresectable, Locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
  41. Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer
  42. Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer
  43. Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
  44. Study of IBI363 in Patients With Advanced First-line Gastric Cancer
  45. A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients with Recurrent Malignant Glioma
  46. Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
  47. The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
  48. A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
  49. Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy
  50. Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma
  51. FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia
  52. A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma
  53. ST-067 and Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma
  54. Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia
  55. A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
  56. Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery (SRS) in Patients With Primary and Secondary Central Nervous System Lymphomas (Lonca-R After SRS in CNSL)

Early Phase 1:

  1. A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients with Advanced Solid Tumors
  2. HS-IT201 Injection in the Treatment of Advanced Solid Tumors
  3. 68Ga-AAZTA-NI-093 PET/CT: First-in-human Study
  4. Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
  5. A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4Ξ± srRNA in Treating Advanced ICC Patients
  6. Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells
  7. Clinical Trial of Anovulatory Infertility

Phase Not Applicable:

  1. Impact of Acupuncture and Manual Therapies on Patients' Quality-of-life in a Hospital-to-community Continuum
  2. Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study
  3. A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers
  4. Feasibility of the Use of Weighted Blankets to Improve Sleep Among Patients with Hematological Malignancies
  5. Evaluating the Impact of an Integrative Oncology Training Program for Healthcare Providers
  6. Comparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1
  7. Opioid-free Anesthesia Protocol for Neurosurgical Supratentorial Tumor Resection
  8. Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA
  9. A Novel Adaptive Anastomotic Technique for Left-sided Colonic Resection
  10. ImmunoPET Imaging of Pancreatic Cancers
  11. Fluid Responsiveness in Posterior Fossa Tumor Resection: PPV and CVP Guidance
  12. Addressing the Nutritional Needs of Cancer Survivors With Nutrition Insecurity
  13. Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy (SABR) Versus SABR Alone for Spinal Metastases
  14. Aromatherapy Oil Associated for Managing Anxiety and Pain During Bone Marrow Biopsy Procedures
  15. Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery
  16. Evaluation of the Safety and Effectiveness of Pringle Method Combined With IVC Flow Limiting and Blocking Method in Laparoscopic Hepatectomy Based on Non-restrictive Fluid Therapy Strategy
  17. Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention
  18. Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid Tumors
  19. Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome
  20. Prognostic IntraOperative Biomarkers IdeNtification in Tumor RElatEd SuRgery
  21. Patient-led Follow-up from Home After Surgery for Colorectal Carcinoma
  22. Enhanced Assistance During Radiotherapy for Unmet Essential Needs
  23. Impact of Aromatherapy on Wellbeing and Relaxation in Gynae Oncology Patients Post Treatment
  24. Evaluating Investigational Medical Device for Breast Tumor Diagnosis Using Diffusion Optical Spectroscopy
  25. Improving Cancer Prevention and Control Through Academic-local Public Health Department Partnerships
  26. Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC
  27. Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy
  28. Validate the Safety and Feasibility of the CT-guided Interventional Robot in Percutaneous Lung Cryablation Procedures
  29. Clinical Trial Protocol to Evaluate the Efficacy and Safety of Laparoscopic Surgical Systems for Gynaecological Surgery
  30. Plasma Exosome RNA to Diagnose Prostate Cancer
  31. Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
  32. Evaluation of an Online Prostate Cancer Screening Decision Aid
  33. Systematic Intervention to Improve Sexual Dysfunction
  34. Rectal Spacers Use in Prostate Cancer Radiation Therapy
  35. Rectal Spacers in Prostate Cancer Patients Undergoing Radiation Therapy
  36. Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer
  37. Magnetic Resonance Imaging (MRI) Guided Stereotactic Adaptive Radiotherapy for Targeting Abdominal Cancer
  38. Fasting-mimicking Diet Intervention on Side Effects of Aromatase Inhibitors Treatment in Patients With Breast Cancer
  39. Evaluation of Clinical Efficacy of Acupuncture in Improving Immune Response in Patients With Cervical Cancer
  40. Multi-Technology Integrated Total Mesorectal Excision Versus Conventional Total Mesorectal Excision for the Treatment of Middle and Distal Rectal Cancer.
  41. Short Questionnaire to Assess Individual Needs in Cancer Survivors in a Clinical Setting
  42. Leveraging the Emergency Department (LEAD) Study
  43. Cancer Literacy As an Essential Factor for Lifestyle Behavior Changes: an Observational and Interventional Study
  44. Virtual Reality on Pain, Fear and Emotional Experience During Port Needle Insertion
  45. The Efficacy and Safety of Benmelstobart for GC/EGC
  46. ALIGN for Older Adults With Cancer in SNFs
  47. Rehabilitation Improved by Early Detection of Fisyulas Post (Pharyngo) -Total Laryngectomy by Cytokine Measurement on Drainage Fluid on the Second Post-Operative Day
  48. Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
  49. Multi-mode Ablation and Molecular Imaging Multi-omics Study for Digestive-Origin Malignant Liver Tumors
  50. Eye Gaze Technology for Endoscopic Inspection of the Gastrointestinal Tract
  51. The Effects of a Food Product Containing Mushroom Extracts (AndoSanTM) in Subjects with Colorectal Cancer-related Fatigue
  52. Impact of Indigo Carmine Pump Spraying on the Adenoma Detection Rate
  53. ACTivating the Immune Response in Ovarian CaNcer
  54. Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer
  55. Impact of Dietary Intervention on Inflammation and Microbiome Composition Post-Colonoscopy
  56. Online Patient Navigation Program for Patients with Breast Cancer
  57. Impact of Acupuncture and Integrative Medicine on Patients Quality-of-life During National Emergency and Wartime
  58. Single-port Robotic Versus Laparoscopic Transanal Total Mesorectal Excision
  59. Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial
  60. Development of Tumor Organoids from Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions
  61. Whey Protein and Carbohydrates in ERAS for Recovery After Thyroidectomy: A Cohort Study
  62. Breast Cancer PSMA PET
  63. Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples
  64. CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCC
  65. The Prognosis Effect of Indocyanine Green (ICG) Fluorescence Guided Surgery on Disease-free Survival (DFS) of Stage III Colorectal Cancer
  66. Effect of Prehabilitation on Head and Neck Cancer Patients
  67. Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer.
  68. Clinical Trial to Evaluate the Efficacy and Safety of a Thoracic and Abdominal Endoscopic Surgical System
  69. The Role and Safety of Radiofrequency Ablation in Recurrent Liver Metastasis of Colorectal Cancer
  70. IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
  71. Can Recurrence of Cancer in the Oropharynx Be Detected by Blood Samples?
  72. Measuring the Density of Iodine in Lipiodol Depositions: Detecting an Invisible Residual Tumor After Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma
  73. BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.
  74. Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma
  75. The Effect of a Mobile Application on Enhancing Pulmonary Rehabilitation After Lung Cancer Surgery
  76. Telerehabilitation in Cancer Patients: Optimization of Prehabilitation and Rehabilitation Following Colorectal Resection
  77. Branched Chained Amino Acid Supplement in Patients Undergoing Lower Limb Bone Cancer Curettage for Bone Metastasis
  78. Exploring Long-term Pain Relief with 5% Dextrose Added to Local Anesthetic
  79. Oral Cryotherapy Applied to Patients Undergoing Chemotherapy
  80. Super-Hypofractionated Partial Breast Irradiation
  81. TNBC Gut Microbiota During Neoadjuvant Treatment
  82. Immuno-effect of TΞ±1 for Stage I NSCLC
  83. RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based
  84. Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)
  85. Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)
  86. Neoadjuvant With TΞ±1 Plus Immuno-chemotherapy for Resectable NSCLC
  87. Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study
  88. Next Generation Sequencing Method for the Detection of EGFR Gene Mutations in the Plasma of Patients with Lung Cancer
  89. A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma
  90. Guaranteed Income and Financial Treatment
  91. A Feasibility Randomized Trial Evaluating Early Vs Late Stent Removal Following Radical Cystectomy and Ileal Conduit Formation for Bladder Cancer
  92. Food for Thought - a Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer
  93. Effect of Yoga Program on Quality of Life in Women With Breast Cancer Receiving Endocrine Therapy
  94. Study on the Impact of Electroacupuncture Combined with Self-Acupressure on the Quality of Life of Patients with Early-Stage Breast Cancer Undergoing Chemotherapy
  95. Exercise for Ameliorating Chemotherapy Cardiotoxicity
  96. Responding to Late Effects in Survivors of Childhood Cancer
  97. Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
  98. Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences
  99. Otago Exercises on the Risk of Falling in Prostatic Cancer Patients Receiving Androgen Deprivation Therapy
  100. Non-pharmacological Care for Depression in Cancer Patients Using VR and TMS
  101. Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC)
  102. Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer
  103. Effectiveness of a PMT Intervention to Reduce Alcohol in Young Adults
  104. Exploring Physiotherapist's Knowledge, Attitudes, Beliefs and Clinical Decision-making Regarding Physical Activity in Chronic Pain Management.
  105. Comparison of ESP and SPSIP Blocks in Breast Surgery
  106. PG Versus TG for Advanced PGC
  107. Online or In-person Interventions on Anxiety and Depression Symptoms in Caregivers of Patients with Cancer
  108. Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery
  109. Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients
  110. A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery
  111. Neuromodulation of Central Sensory Integration to Improve Postural Control
  112. Safety of Microporous Annealed Particle (MAP) Wound Matrix in Patients with Clean Surgical Wounds.
  113. Molecular Pituitary Imaging Using 18F-FET PET
  114. Endoscopic Ultrasound-guided Fine-needle Biopsy for Tissue Sampling of Biliary Strictures: a Multicenter Prospective Study
  115. Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
  116. Feasibility and Safety of Remote Robotic Bronchoscopy System in Diagnosis of Peripheral Pulmonary Lesions: a Multicenter, Randomized Controlled, Proof-of Concept Trial
  117. dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma
  118. ATezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma
  119. TACE With Thermosensitive Nanogel Versus Embosphere for HCC
  120. Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma
  121. Spectral Focused Imaging Versus White Light Imaging in Colorectal Adenoma Detection
  122. The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma
  123. Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma
  124. Cooking for Your Health in Southern New Mexico: an 8-week, Bilingual (English and Spanish) Nutritional Intervention in Adults Living in DoΓ±a Ana and Otero Counties
  125. BHB & CAR-T for Lymphomas
  126. Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia
  127. MOLyF : Bone Marrow and Follicular Lymphoma
  128. Baker Cyst Aspiration Combined with Platelet-rich Plasma Injection in Knee Osteoarthritis
  129. Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS

Note

The above Clinical Trial information has been retrieved from ClinicalTrials.gov